Intensive Cognitive-Behavioral Therapy For Obsessive-Compulsive Disorder
Cognitive-Behavioral Therapy and Glutamate in Cingulate Gyrus in OCD
1 other identifier
interventional
75
1 country
1
Brief Summary
Even with the best available treatments for obsessive-compulsive disorder (OCD), most patients only partially recover and many patients do not respond at all. Such incomplete and inadequate response contributes to greater public health costs in terms of morbidity and patient care expenses. This study aims for a better understanding of abnormal brain chemistry in OCD and how it is affected by cognitive-behavioral therapy (CBT) in order to develop novel therapies and improve the success of existing therapies. The main hypothesis is that CBT will change levels of the excitatory neurotransmitter glutamate in OCD patients in a region of the brain involved in OCD known as the cingulate cortex.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2011
CompletedFirst Posted
Study publicly available on registry
June 8, 2011
CompletedStudy Start
First participant enrolled
July 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedMarch 24, 2020
March 1, 2020
3.9 years
June 6, 2011
March 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRSI glutamate
Regional concentration of glutamate in brain, as measured by magnetic resonance spectroscopic imaging (MRSI)
4 weeks
Secondary Outcomes (1)
Y-BOCS
4 weeks
Study Arms (3)
OCD Active CBT
EXPERIMENTALAdults with obsessive-compulsive disorder (OCD) will be treated with cognitive-behavioral therapy (CBT) from the time of enrollment.
OCD Waitlist
ACTIVE COMPARATORAdults with OCD will receive waitlist treatment at enrollment. Nonresponders will cross over to CBT.
Healthy Control
NO INTERVENTIONHealthy control adults will be given no intervention.
Interventions
Nondrug psychotherapy administered daily 5 days/week for 4 weeks
Eligibility Criteria
You may qualify if:
- meets DSM-IV-TR diagnostic criteria for OCD as primary (most severe) diagnosis based on Anxiety Disorders Interview Schedule (ADIS) Clinical Severity Rating
- reported DSM-IV-TR-threshold OCD symptom onset age 18 or later
- Yale-Brown Obsessive-Compulsive total score greater than or equal to 16
- fluent English speaker
- signed informed consent
You may not qualify if:
- IQ of less than 80 on the Wechsler Abbreviated Scales of Intelligence
- lifetime DSM-IV diagnosis of pervasive developmental disorder, mania, psychosis, conduct disorder, or substance dependence assessed through ADIS
- current DSM-IV diagnosis of major depressive disorder if ADIS CSR rating is 4 or higher (severe) or attention-deficit hyperactivity disorder
- primary compulsive hoarding
- any changes (dose or agent) in psychotropic medication for OCD or other psychiatric condition within 12 weeks prior to enrollment
- severe illness that requires immediate inpatient psychiatric intervention
- any serious psychiatric, psychosocial, or neurological condition requiring immediate treatment other than that provided in the current study
- any body metal (other than dental fillings), positive pregnancy test, or other MR scan contraindications
- prior trial of CBT for OCD, regardless of outcome
- medical conditions that affect cerebral metabolism (e.g., thyroid disorders or diabetes)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UCLA Obsessive-Compulsive Disorder Intensive Treatment Program
Los Angeles, California, 90024, United States
Related Publications (2)
Reggente N, Moody TD, Morfini F, Sheen C, Rissman J, O'Neill J, Feusner JD. Multivariate resting-state functional connectivity predicts response to cognitive behavioral therapy in obsessive-compulsive disorder. Proc Natl Acad Sci U S A. 2018 Feb 27;115(9):2222-2227. doi: 10.1073/pnas.1716686115. Epub 2018 Feb 12.
PMID: 29440404DERIVEDMoody TD, Morfini F, Cheng G, Sheen C, Tadayonnejad R, Reggente N, O'Neill J, Feusner JD. Mechanisms of cognitive-behavioral therapy for obsessive-compulsive disorder involve robust and extensive increases in brain network connectivity. Transl Psychiatry. 2017 Sep 5;7(9):e1230. doi: 10.1038/tp.2017.192.
PMID: 28872637DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph O'Neill, PhD
UCLA Child Psychiatry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof Child Psychiatry
Study Record Dates
First Submitted
June 6, 2011
First Posted
June 8, 2011
Study Start
July 1, 2011
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
March 24, 2020
Record last verified: 2020-03